𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Speech in spinocerebellar ataxia

✍ Scribed by Schalling, Ellika; Hartelius, Lena


Book ID
121779564
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
403 KB
Volume
127
Category
Article
ISSN
0093-934X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Spinocerebellar ataxias
✍ Mario Mascalchi πŸ“‚ Article πŸ“… 2008 πŸ› Springer Milan 🌐 English βš– 105 KB
Spinocerebellar Ataxias
✍ Huda Y. Zoghbi πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 192 KB
The Spinocerebellar Ataxias
✍ Paulson, Henry L πŸ“‚ Article πŸ“… 2009 πŸ› Lippincott Williams and Wilkins 🌐 English βš– 77 KB
Movement disorders in spinocerebellar at
✍ Jose Luiz Pedroso; Andre C. Felicio; Pedro Braga-Neto; Orlando G.P. Barsottini πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 44 KB

We read the article by van Gaalen et al. 1 with great interest. These authors reviewed the frequency and main type of movement disorders found in each form of spinocerebellar ataxia (SCA). They also reported unusual movement disorders and noncerebellar manifestations, such as stiff-person syndrome,

Movement disorders in spinocerebellar at
✍ Judith van Gaalen; Paola Giunti; Bart P. van de Warrenburg πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

## Abstract Autosomal dominant spinocerebellar ataxias (SCAs) can present with a large variety of noncerebellar symptoms, including movement disorders. In fact, movement disorders are frequent in many of the various SCA subtypes, and they can be the presenting, dominant, or even isolated disease fe

Depression comorbidity in spinocerebella
✍ Tanja Schmitz-HΓΌbsch; Mathieu Coudert; Sophie Tezenas du Montcel; Paola Giunti; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

## Abstract This is a description of the prevalence and profile of depressive symptoms in dominant spinocerebellar ataxia (SCA). Depressive symptoms were assessed in a convenience sample of 526 genetically confirmed and clinically affected patients (117 SCA1, 163 SCA2, 139 SCA3, and 107 SCA6) using